April 2023 FAQs
- What clinical evidence supports the use of lecanemab for Alzheimer disease?
- What considerations should pharmacists make in relation to teplizumab use in patients with type 1 diabetes mellitus?
- What data are available for sublingual dexmedetomidine in the treatment of acute agitation related to schizophrenia or bipolar disorder?